U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07154953) titled 'Serum Surfactant Protein-D as Predictor of Disease Severity in Hospitalized COPD Patients' on Aug. 27.
Brief Summary: evaluation of the serum levels of surfactant protein-D (SP-D), C-reactive protein (CRP), fibrinogen, and peripheral blood neutrophilic and eosinophilic counts in patients with COPD correlation of these biomarkers with clinical, functional, and radiological parameters
Study Start Date: Dec. 01, 2025
Study Type: OBSERVATIONAL
Condition:
COPD
Intervention:
DIAGNOSTIC_TEST: Serum Surfactant Protein-D
Several studies support the use of SP-D as a marker of systemic inflammation and lung tissue damage in COPD.Measuri...